HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Haan, J. Articles by Eijgelaar, A. Search for Related Content PubMed PubMed Citation Articles by de Haan, J. Articles by Eijgelaar, A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 106, 1017-1023, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass

J de Haan, J Schonberger, J Haan, W van Oeveren and A Eijgelaar
Department of Cardiopulmonary Surgery, University Hospital Groningen, The Netherlands.

Reduced hemostasis and bleeding tendency after cardiopulmonary bypass results from platelet dysfunction induced by the bypass procedure. The causes of this acquired platelet dysfunction are still subject to discussion, although, recently, greater emphasis has been placed on an overstimulated fibrinolytic system as a probable cause. In the first part of this study we assessed the effects of postoperative retransfusion of shed blood on blood loss to patients undergoing cardiopulmonary bypass. We observed that increasing concentrations of fibrinogen degradation products and tissue-type plasminogen activator stimulating activity in shed blood correlated significantly with a higher postoperative bleeding tendency (p < 0.05 for both). We further noted that retransfusion of shed blood increased the total postoperative blood loss by 43% (925 versus 1320 ml, p < 0.05). On the basis of these clinical observations, we hypothesized that the increased bleeding tendency was caused by fibrinolysis. In the second part of this study we collected evidence in support of this hypothesis by an in vitro study, in which we introduced similar (pro)fibrinolytic activity to platelet-rich plasma and measured the influence of this treatment on platelet function indicated by ristocetin agglutination. Tissue-type plasminogen activator and fibrin monomers (tissue-type plasminogen activator stimulator) together induced severe platelet damage, resulting in a decreased ristocetin agglutination response. Therefore, we propose a fibrinolysis-related mechanism for platelet dysfunction during cardiopulmonary bypass, dependent on fibrinolytic factors such as fibrin monomers, D-dimers, and tissue-type plasminogen activator.

This article has been cited by other articles:

				E. Sirvinskas, A. Veikutiene, R. Benetis, P. Grybauskas, J. Andrejaitiene, V. Veikutis, and J. Surkus Influence of early re-infusion of autologous shed mediastinal blood on clinical outcome after cardiac surgery Perfusion, September 1, 2007; 22(5): 345 - 352. [Abstract] [PDF]

				F. D. Rubens and H. Nathan Lessons learned on the path to a healthier brain: dispelling the myths and challenging the hypotheses Perfusion, May 1, 2007; 22(3): 153 - 160. [Abstract] [PDF]

				A. Castiglioni, A. Verzini, F. Pappalardo, N. Colangelo, L. Torracca, A. Zangrillo, and O. Alfieri Minimally Invasive Closed Circuit Versus Standard Extracorporeal Circulation for Aortic Valve Replacement Ann. Thorac. Surg., February 1, 2007; 83(2): 586 - 591. [Abstract] [Full Text] [PDF]

				J. Karski, G. Djaiani, J. Carroll, M. Iwanochko, P. Seneviratne, P. Liu, W. Kucharczyk, L. Fedorko, T. David, and D. Cheng Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: A prospective randomized controlled clinical trial J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 309 - 314. [Abstract] [Full Text] [PDF]

				J. M. Albes, I. M. Stohr, M. Kaluza, A. Siegemund, D. Schmidt, R. Vollandt, and T. Wahlers Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1504 - 1512. [Abstract] [Full Text] [PDF]

				S. Dial, D. Nguyen, and D. Menzies Autotransfusion of Shed Mediastinal Blood: A Risk Factor for Mediastinitis After Cardiac Surgery? Results of a Cluster Investigation Chest, November 1, 2003; 124(5): 1847 - 1851. [Abstract] [Full Text] [PDF]

				M. Johnell, G. Elgue, R. Larsson, A. Larsson, S. Thelin, and A. Siegbahn Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 321 - 332. [Abstract] [Full Text] [PDF]

				A Pierangeli, V Masieri, F Bruzzi, E De Toni, G Grillone, P Boni, and A Delnevo Haemolysis during cardiopulmonary bypass: how to reduce the free haemoglobin by managing the suctioned blood separately Perfusion, December 1, 2001; 16(6): 519 - 524. [Abstract] [PDF]

				M H Cross Autotransfusion in cardiac surgery Perfusion, September 1, 2001; 16(5): 391 - 400. [Abstract] [PDF]

				H. I. Flom-Halvorsen, E. Ovrum, G. Tangen, F. Brosstad, M.-A. L. Ringdal, and R. Oystese AUTOTRANSFUSION IN CORONARY ARTERY BYPASS GRAFTING: DISPARITY IN LABORATORY TESTS AND CLINICAL PERFORMANCE J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 610 - 617. [Abstract] [Full Text] [PDF]

				R. A. Vertrees, V. R. Conti, S. D. Lick, J. B. Zwischenberger, L. B. McDaniel, and G. Shulman Adverse Effects of Postoperative Infusion of Shed Mediastinal Blood Ann. Thorac. Surg., September 1, 1996; 62(3): 717 - 723. [Abstract] [Full Text]

				Y. J. Gu, J. de Haan, U. P. M. Brenken, W. J. de Boer, Jm. Prop, W. van Oeveren, and G. L. T. Group CLOTTING AND FIBRINOLYTIC DISTURBANCE DURING LUNG TRANSPLANTATION: EFFECT OF LOW-DOSE APROTININ J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 599 - 606. [Abstract] [Full Text]

				D. M. Nguyen, B. M. Gilfix, F. Dennis, D. Blank, D. A. Latter, P. L. Ergina, J. E. Morin, and B. de Varennes Impact of Transfusion of Mediastinal Shed Blood on Serum Levels of Cardiac Enzymes Ann. Thorac. Surg., July 1, 1996; 62(1): 109 - 114. [Abstract] [Full Text]

				S. Cicek, H. Tatar, U. Demirklc, and E. Kuralay Topical use of aprotinin in cardiac surgery J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 568 - 569. [Full Text]

				J. de Haan, P. W. Boonstra, S. H. J. Monnink, T. Ebels, and W. van Oeveren Retransfusion of Suctioned Blood During Cardiopulmonary Bypass Impairs Hemostasis Ann. Thorac. Surg., April 1, 1995; 59(4): 901 - 907. [Abstract] [Full Text]

				N. Tabuchi, J. de Haan, and W. van Oeveren Topical effect of aprotinin on the surgical wound in cardiac surgery J. Thorac. Cardiovasc. Surg., February 1, 1995; 109(2): 399 - 400. [Full Text]